Home/Pipeline/Akynzeo (netupitant/palonosetron)

Akynzeo (netupitant/palonosetron)

Chemotherapy-Induced Nausea and Vomiting

ApprovedActive

Key Facts

Indication
Chemotherapy-Induced Nausea and Vomiting
Phase
Approved
Status
Active
Company

About Angelini Pharma

Angelini Pharma is a century-old, private Italian pharmaceutical company with a significant international commercial footprint across Europe and the United States. Its strategy is built on a diversified portfolio spanning prescription drugs in Brain Health, Specialty Care, and over-the-counter Consumer Healthcare products. The company demonstrates a clear commitment to its core therapeutic areas through ongoing commercial initiatives, medical education platforms like Headway, and a pipeline that includes recently launched CNS products such as Ontozry.

View full company profile

Other Chemotherapy-Induced Nausea and Vomiting Drugs

DrugCompanyPhase
Fosaprepitant for InjectionPraxgen PharmaceuticalsApproved